First Pacific Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.65M Sell
39,660
-211
-0.5% -$32K 0.58% 30
2026
Q2
$6.25M Sell
39,871
-51
-0.1% -$7.65K 0.74% 21
2026
Q1
$6.1M Sell
39,922
-150
-0.4% -$23K 0.79% 20
2025
Q4
$5.52M Buy
40,072
+5,759
+17% +$754K 0.72% 26
2025
Q3
$4.4M Buy
34,313
+8,258
+32% +$1.01M 0.61% 31
2025
Q2
$3.15M Buy
+26,055
New +$2.94M 0.46% 36

Other funds holding NVS

First Pacific Financial's NVS Position: Q3 2026 in Review

First Pacific Financial reduced its Novartis (NVS) stake by 0.53% in Q3 2026, selling an estimated $32K and leaving 39,660 shares worth $5.65M. The position accounts for 0.58% of the portfolio, ranked #30.

First Pacific Financial first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.25M in Q2 2026. 227 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • First Pacific Financial held 39,660 shares of Novartis worth $5.65M as of Q3 2026.
  • First Pacific Financial sold 211 Novartis shares in Q3 2026, an estimated $32K.
  • Novartis made up 0.58% of First Pacific Financial's portfolio in Q3 2026, its #30 holding.
  • First Pacific Financial first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
  • First Pacific Financial's Novartis position peaked at $6.25M in Q2 2026.
  • 227 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on First Pacific Financial's 13F filing for Q3 2026, filed 14 Oct 2026.